(377 days)
Not Found
No
The summary describes a passive implantable device made of PEEK with no mention of software, algorithms, or any technology that would suggest AI/ML capabilities. The performance studies are biomechanical tests, not related to data analysis or image processing.
No.
The device is an intervertebral body fusion device and is intended to be used with autogenous bone graft and a supplemental internal spinal fixation system. Its purpose is to facilitate spinal fusion and provide structural support, not to directly treat a disease or condition through therapeutic action.
No
Explanation: The device is an intervertebral body fusion device intended for spinal fusion procedures, not for diagnosing conditions.
No
The device description explicitly states the device is fabricated from Polyetheretherketone (PEEK-OPTIMA LT1) and is an implantable intervertebral body fusion device, indicating it is a physical hardware device.
Based on the provided information, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- Intended Use: The intended use clearly describes a surgical implant for spinal fusion. This is a therapeutic procedure performed directly on the patient's body.
- Device Description: The device is described as an intervertebral body fusion device made of PEEK, designed to be implanted in the spine. This is a physical implant, not a reagent, instrument, or system used to examine specimens from the human body.
- Lack of IVD Characteristics: There is no mention of the device being used to test or analyze biological samples (blood, urine, tissue, etc.) to provide information about a patient's health status, diagnose a condition, or monitor treatment.
IVD devices are used in vitro (outside the body) to examine specimens. This device is used in vivo (inside the body) as a surgical implant.
N/A
Intended Use / Indications for Use
The Small PLATEAU Spacer System is intended for spinal fusion procedures in skeletally mature patients with degenerative disc disease (DDD) at one disc level (C2-T1). DDD is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. It is to be used in patients who have had at least six weeks of non-operative treatment. This device is intended to be used with autogenous bone graft and a supplemental internal spinal fixation system.
Product codes
ODP
Device Description
The Small PLATEAU Spacer System is intended to serve as an intervertebral body fusion device. The implant is available in a range of sizes and footprints to suit the individual pathology and anatomical conditions of the patient. It is fabricated and manufactured from Polyetheretherketone (PEEK-OPTIMA LT1) with radiographic markers. The implant is hollow to permit packing with bone graft to help promote intervertebral body fusion. The superior and inferior surfaces have teeth to assist in the interface with the vertebral endplates to prevent rotation and/or migration.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
C2-T1 (Disc level)
Indicated Patient Age Range
skeletally mature patients
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Biomechanical testing in accordance with ASTM standards was conducted to demonstrate substantial equivalence to the predicate intervertebral body fusion devices. Invibio, the manufacturer and supplier of the raw PEEK-OPTIMA material, has proven biocompatibility for implantable contact greater than 30 days to the ISO 10993 standard. Independent laboratories have performed the relevant ISO 10993 testing to ensure that PEEK-OPTIMA is a biocompatible material. In addition, biomechanical testing was conducted to demonstrate substantial equivalency of the Small PLATEAU Spacer System to the predicate devices. Static axial compression, static expulsion, static subsidence, static torsion, dynamic axial compression, and dynamic torsion tests were performed on 14mm x 14mm, 7 implants. The results of these tests demonstrate that the Small PLATEAU Spacer System is substantially equivalent to the predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 888.3080 Intervertebral body fusion device.
(a)
Identification. An intervertebral body fusion device is an implanted single or multiple component spinal device made from a variety of materials, including titanium and polymers. The device is inserted into the intervertebral body space of the cervical or lumbosacral spine, and is intended for intervertebral body fusion.(b)
Classification. (1) Class II (special controls) for intervertebral body fusion devices that contain bone grafting material. The special control is the FDA guidance document entitled “Class II Special Controls Guidance Document: Intervertebral Body Fusion Device.” See § 888.1(e) for the availability of this guidance document.(2) Class III (premarket approval) for intervertebral body fusion devices that include any therapeutic biologic (e.g., bone morphogenic protein). Intervertebral body fusion devices that contain any therapeutic biologic require premarket approval.
(c)
Date premarket approval application (PMA) or notice of product development protocol (PDP) is required. Devices described in paragraph (b)(2) of this section shall have an approved PMA or a declared completed PDP in effect before being placed in commercial distribution.
0
510(k) Submission Plateau-C Spacer System
| Submitted By: | Life Spine, Inc.
2401 W. Hassell Road, Suite 1535
Hoffman Estates, IL 60169
Telephone: 847-884-6117
Fax: 847-884-6118 |
|-----------------|--------------------------------------------------------------------------------------------------------------------------------------------------|
| 510(k) Contact: | Randy Lewis
Life Spine, Inc.
2401 W. Hassell Road, Suite 1535
Hoffman Estates, IL 60169
Telephone: 847-884-6117
Fax: 847-884-6118 |
| Date Prepared: | October 5th, 2010 |
| Trade Name: | Plateau-C Spacer System |
| Common Name: | Intervertebral Body Fusion Device |
| Classification: | ODP, 21 CFR 888.3080, Class II |
510(k) Summary Small PLATEAU® (PLATEAU-C) Spacer System
Device Description:
The Small PLATEAU Spacer System is intended to serve as an intervertebral body fusion device. The implant is available in a range of sizes and footprints to suit the individual pathology and anatomical conditions of the patient. It is fabricated and manufactured from Polyetheretherketone (PEEK-OPTIMA LT1) with radiographic markers. The implant is hollow to permit packing with bone graft to help promote intervertebral body fusion. The superior and inferior surfaces have teeth to assist in the interface with the vertebral endplates to prevent rotation and/or migration.
Intended Use of the Device:
The Small PLATEAU Spacer System is intended for spinal fusion procedures in skeletally mature patients with degenerative disc disease (DDD) at one disc level (C2-T1). DDD is defined as discogenic pain with degeneration of the disc confirmed by history and radiographic studies. It is to be used in patients who have had at least six weeks of non-operative treatment. This device is intended to be used with autogenous bone graft and a supplemental internal spinal fixation system.
1
Performance Data:
Biomechanical testing in accordance with ASTM standards was conducted to demonstrate substantial equivalence to the predicate intervertebral body fusion devices.
Test Data
Invibio, the manufacturer and supplier of the raw PEEK-OPTIMA material, has proven biocompatibility for implantable contact greater than 30 days to the ISO 10993 standard. Independent laboratories have performed the relevant ISO 10993 testing to ensure that PEEK-OPTIMA is a biocompatible material. Invibio has device master files MAF 1209 containing the ISO 10993 testing as well as additional testing and extensive data concerning the polymer and its manufacturing methods, lodged with the Food and Drug Administration. Life Spine has been granted access letters for these files. These access letters can be found in Appendix H.
In addition, biomechanical testing was conducted to demonstrate substantial equivalency of the Small PLATEAU Spacer System to the predicate devices. Static axial compression, static expulsion, static subsidence, static torsion, dynamic axial compression, and dynamic torsion tests were performed on 14mm x 14mm, 7 implants, which was determined to be the optimal size implant to match the predicate testing as outlined in ASTM F2077 and F2267.
This construct was determined to be the worst case construct as the cross sectional area of these implants does not change as the height changes. Additionally, this configuration of the Small PLATEAU Spacer System embodies the worst case scenario wall thickness and therefore represents the worst case construct for testing.
The worst case scenario constructs per ASTM F2077 and F2267 guidelines were assembled at Empirical Testing, an independent testing facility. The results of these tests can be found in Empirical Testing Technical Report #199-534806-115 in Appendix B.
The test results demonstrate that the Small PLATEAU Spacer System is substantially equivalent to the predicate devices.
Substantial Equivalence:
Equivalent Products
The Small PLATEAU Spacer System is substantially equivalent to the Spinal Elements Crystal (K073351), the US Spine Phantom Plus Cage System (K082801), and the DePuy Bengal System (K081917).
Equivalency
Based upon the information presented in the Summary of Design Comparison Table (Table 1) below, the Small PLATEAU Spacer System is substantially equivalent in design, materials, function and indications for use to the predicate devices presented.
2
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
OCT 1 3 2010
Life Spine, Inc. % Mr. Randy Lewis 2401 West Hassell Road, Suite 1535 Hoffman Estates, Illinois 60169
Re: K093093
Trade/Device Name: Small PLATEAU® (PLATEAU-C) Spacer System Regulation Number: 21 CFR 888.3080 Regulation Name: Intervertebral body fusion device Regulatory Class: Class II Product Code: ODP Dated: October 05, 2010 Received: October 06, 2010
Dear Mr. Lewis:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you; however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must
3
Page 2 - Mr. Randy Lewis
comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm.
Sincerely yours,
Mark N. Melkerson
Director Division of Surgical, Orthopedic And Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
Indications for Use Form
Indications for Use
| 510(k) Number: | K093093 |
|---|---|
| Device Name: | Small PLATEAU® (PLATEAU-C) Spacer System |
| Indications for Use: | The Small PLATEAU Spacer System is intended for spinal fusion |
| procedures in skeletally mature patients with degenerative disc | |
| disease (DDD) at one disc level (C2-T1). DDD is defined as | |
| discogenic pain with degeneration of the disc confirmed by history | |
| and radiographic studies. It is to be used in patients who have had | |
| at least six weeks of non-operative treatment. This device is | |
| intended to be used with autogenous bone graft and a supplemental | |
| internal spinal fixation system. |
Prescription Use √ (Part 21 CFR 801 Subpart D)
. .
AND/OR
Over-The-Counter Use __ (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED) ・.
Concurrence of CDRH, Office of Device Evaluation (ODE)
.. . . . . .
(Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices
510(k) Number_________________________________________________________________________________________________________________________________________________________________
Page 1 of 1
. '